Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boers

Showing results (11-20 of 277) with videos related to

Pageof 28
Sort By:
Lancet (London, England)|November 18, 2000
Value of magnetic resonance imaging in rheumatoid arthritis?M Boers
The Netherlands Journal of Medicine|August 1, 1993
International consensus on which measures to use in rheumatoid arthritis clinical trialsM Boers
The Journal of Rheumatology|December 1, 1991
Impaired renal function and colchicine toxicityM Boers
Rheumatology (Oxford, England)|May 26, 1999
The case for corticosteroids in the treatment of early rheumatoid arthritisM Boers
The Journal of Rheumatology|September 1, 1995
The validity of radiography as outcome measure in rheumatoid arthritisM Boers
Annals of the Rheumatic Diseases|September 24, 2009
The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: a systematic comparison of 3- and 6-month response rates in trials of biological agentsM Boers
Arthritis and Rheumatism|April 1, 1991
Low-dose prednisone in rheumatoid arthritis patients: placebo treatment?M Boers
Clinical and Experimental Rheumatology|October 25, 2011
The COBRA trial 20 years laterM Boers
Seminars in Arthritis and Rheumatism|August 1, 1990
Renal disorders in rheumatoid arthritisM Boers
Lancet (London, England)|September 18, 1999
Combination therapy in rheumatoid arthritisM Boers
Pageof 28

Showing results (11-20 of 277) with videos related to

Sort By:
Pageof 28
Lancet (London, England)|November 18, 2000
Value of magnetic resonance imaging in rheumatoid arthritis?M Boers
The Netherlands Journal of Medicine|August 1, 1993
International consensus on which measures to use in rheumatoid arthritis clinical trialsM Boers
The Journal of Rheumatology|December 1, 1991
Impaired renal function and colchicine toxicityM Boers
Rheumatology (Oxford, England)|May 26, 1999
The case for corticosteroids in the treatment of early rheumatoid arthritisM Boers
The Journal of Rheumatology|September 1, 1995
The validity of radiography as outcome measure in rheumatoid arthritisM Boers
Annals of the Rheumatic Diseases|September 24, 2009
The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: a systematic comparison of 3- and 6-month response rates in trials of biological agentsM Boers
Arthritis and Rheumatism|April 1, 1991
Low-dose prednisone in rheumatoid arthritis patients: placebo treatment?M Boers
Clinical and Experimental Rheumatology|October 25, 2011
The COBRA trial 20 years laterM Boers
Seminars in Arthritis and Rheumatism|August 1, 1990
Renal disorders in rheumatoid arthritisM Boers
Lancet (London, England)|September 18, 1999
Combination therapy in rheumatoid arthritisM Boers
Pageof 28